Processa pharmaceuticals provides data update supporting a potential personalized treatment approach for improved cancer care

Interim analysis of ph ase 1b data suggests processa's novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient
PCSA Ratings Summary
PCSA Quant Ranking